Abbott Laboratories (ABT) reported that its second-quarter net earnings declined to $1.725 billion or $1.08 per share, from $1.943 billion or $1.23 per share in the same quarter last year.
Net Earnings, excluding specified items, were $1.966 billion or $1.23 per share, compared to $1.768 billion or $1.12 per share last year. Analysts polled by Thomson Reuters expected the company to report earnings of $1.22 per share for the quarter. Analysts' estimates typically exclude special items.
Net sales for the quarter rose to $9.807 billion from $9.616 billion in the prior year quarter. Seventeen analysts had consensus revenue estimate of $9.84 billion for the quarter.
The company confirmed its ongoing earnings-per-share guidance for 2012 of $5.00 to $5.10, reflecting another year of expected strong performance. Analysts expect the company to report earnings of $5.04 per share for fiscal 2012.
Including specified items, projected earnings per share under GAAP would be $4.29 to $4.39 for the full-year 2012. Earlier, Including special items, the company had expected reported earnings for the year of $4.48 to $4.58 per share.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.